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Postoperative analgesic effect, of
preoperatively administered
dexamethasone, after operative fixation of
fractured neck of femur: randomised,
double blinded controlled study
Szilard Szucs1*, David Jessop2, Gabriella Iohom1 and George D. Shorten1
Abstract
Background: Fractured neck of femur is a common cause of hospital admission in the elderly and usually requires
operative fixation. In a variety of clinical settings, preoperative glucocorticoid administration has improved analgesia
and decreased opioid consumption. Our objective was to define the postoperative analgesic efficacy of single dose
of dexamethasone administered preoperatively in patients undergoing operative fixation of fractured neck of femur.
Methods: Institutional ethical approval was granted and written informed consent was obtained from each
patient. Patients awaiting for surgery at Cork University Hospital were recruited between July 2009 and August 2012.
Participating patients, scheduled for surgery were randomly allocated to one of two groups (Dexamethasone or
Placebo). Patients in the dexamethasone group received a single dose of intravenous dexamethasone 0.1 mg kg -1
immediately preoperatively. Patients in the placebo group received the same volume of normal saline. Patients
underwent operative fixation of fractured neck of femur using standardised spinal anaesthesia and surgical techniques.
The primary outcome was pain scores at rest 6 h after the surgery.
Results: Thirty seven patients were recruited and data from thirty patients were analysed. The groups were similar in
terms of patient characteristics. Pain scores at rest 6 h after the surgery (the principal outcome) were lesser in
the dexamethasone group compared with the placebo group [0.8(1.3) vs. 3.9(2.9), mean(SD) p = 0.0004]. Cumulative
morphine consumption 24 h after the surgery was also lesser in the dexamethasone group [7.7(8.3) vs. 15.1(9.4),
mean(SD) mg, p = 0.04].
Conclusions: A single dose of intravenous dexamethasone 0.1 mg kg -1 administered before operative fixation of
fractured neck of femur improve significantly the early postoperative analgesia.
Trial registration: ClinicalTrials.gov identifier: NCT01550146, date of registration: 07/03/2012
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Background
Fractured neck of femur (FNF) is a common cause of hos-
pital admission in the elderly and requires operative fixation
with an associated mortality of 5–8 % at 3 months [1].
Dexamethasone is a synthetic adrenocortical steroid,
used widely in anaesthesia as an antiemetic in surgical
patients. Dexamethasone inhibit cortisol secretion by
inhibiting the hypothalamo-pituitary-adrenal axis. At the
pituitary level inhibition involving changes in transcrip-
tion [2, 3]. Cortisol exists in free (unbounded) and
protein-bound forms in serum but only in a free form in
saliva. The free form is the biologically active one [4].
Glucocorticoids are inhibitors of both phospholipase
and cyclooxygenase enzyme, intravenously administered
dexamethasone 16 mg provides prolonged postoperative
analgesia from 24 to 72 h after breast surgery [5]. Pre-
operative dexamethasone reduce postoperative nausea,
has a prolonged suppressive effect on the inflammatory
response and decreases dynamic pain 24 h after total hip
arthroplasty [6]. Administration of i.v. dexamethasone
prior to intrathecal meperidine injection enhance post-
operative analgesia and reduces postoperative nausea
and vomiting [7].
Recently were published two editorials which were
emphasised the potential side effects of single dose of
dexamethasone [8, 9], however the authors agreed that
further evidence needed to justify to not administer dexa-
methasone in patients with low risk for the side effects.
Single dose dexamethasone has not been evaluated for
its effects on postoperative pain and the inflammatory
response to surgery in surgical fixation of FNF.
In this study, our hypothesis was that preoperative ad-
ministration of a single dose of dexamethasone 0.1 mg kg -1
enhances postoperative analgesia 6 h after the surgery in
patients undergoing operative fixation of FNF. Previous
clinical studies used dexamethasone from low [7] dose to
high dose [6]. Taking into consideration the anticipated
age profile of our patients and the associated lesser meta-
bolic rate we selected a lesser dose, 0.1 mg kg -1, of
dexamethasone. The primary outcome parameter was
pain score at rest 6 h after surgery.
Methods
With institutional ethical approval [Clinical Research Ethics
Committee of the Cork Teaching Hospitals [(ECM 3 (bbbb)
07/07/09.)] and having retrospectively registered with
ClinicalTrials.gov (NCT01550146), a prospective, double-
blind, randomised, placebo-controlled trial was under-
taken at Cork University Hospital, Cork, Ireland between
July 2009 and August 2012. Patients were randomly
assigned to receive either preoperative single dose of
dexamethasone or the same volume of normal saline as
placebo (Dexamethasone D or Placebo P). We used a ran-
dom number tables and sealed envelopes prepared by one
of the co-author (GI). Based on the randomisation the so-
lution was prepared by a different anaesthetist and was
administer by a blinded anaesthesia provider not involved
in the study. The anaesthetist and the independent obser-
ver were both blinded. Written, informed consent was
obtained from all patients.
Patients admitted on to the Emergency Department at
Cork University Hospital with FNF, American Society of
Anaesthesiologists grades I -III and aged >65 years, were
invited to participate in the study. Exclusion criteria
were endocrine disorders (including I and II type of
Diabetes mellitus), prior diagnosis of depression, cortico-
steroid treatment (in any form) within the previous last
4 months, Mini-Mental Score < 22, coagulation disorders,
head injury, other associated injuries, loss of conscious-
ness, renal dysfunction and sepsis.
Patients in group D received a single dose of dexa-
methasone 0.1 mg kg -1 (1 mg ml -1) i.v. on arrival to the
operating theatre (prior to performance of a femoral nerve
block to facilitate positioning for spinal anaesthesia).
Patients in group P received the same volume 0.1 ml kg -1
of normal saline i.v on arrival to the operating theatre.
On arrival to the operating theatre, an 18 G cannula
was inserted for i.v. drugs and fluid administration.
Ultrasound-guided femoral nerve block (15 mls of 2 %
lignocaine) was performed to facilitate positioning for
spinal anaesthesia, which was performed using hyperbaric
bupivacaine (11 mg in patients < 70 kg and 12.5 mg in
patients > 70 kg) through a 25 G spinal needle.
All patients received paracetamol 1 g i.v. during surgery
and six hourly thereafter for a week. Rescue analgesia con-
sisted of 5–10 mg morphine i.m.
An independent blinded observer assessed pain severity
at rest and on movement using a numeric rating score
(NRS) (0–no pain; 10-worst pain imaginable) on arrival to
the operating theatre, on arrival to recovery, and at 6, 12,
24, 48, 72 h and 1 week post-operatively. Salivary cortisol
level was measured by radioimmunoassay [10].
Patients were evaluated for Nausea/Vomiting, sedation
and pruritus (4 on a observational scale 1–4) by the in-
dependent blinded observer at the same time points.
Analgesic consumption were also recorded.
Statistical analysis
Quantitative data were tested for normality and, as ap-
propriate, analysed using the unpaired two-tail Student
t test. Categorical data were examined using Chi-squared
test (or Fisher’s Exact Test as appropriate). P < 0.05 was
considered significant.
Power analysis was performed based on the data pub-
lished in a previous publication [11] which correlates
with our previously published data [12]. To detect a
50 % decrease in pain scores 6 h after the surgery, with a
two-sided 5 % significance level and a power of 80 %, it
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was calculated that the minimum sample size was 17
patients per group.
Results
Thirty seven patients were recruited to this study of
whom 30 were managed per protocol. Seven patients
were excluded: in two cases, the patients’ mental status
deteriorated after recruitment and in five cases, it was
elected to perform the surgery under general anaesthesia
for reasons unrelated to the study (Fig. 1). In the dexa-
methasone group one patient was excluded from the
analysis because of mental status deterioration after re-
cruitment and in three cases, surgery was performed
under general anaesthesia for clinical reasons independent
of the study. Patient characteristics were similar in the
two groups (Table 1).
The pain scores at rest 6 h after the surgery were lesser
in the dexamethasone group compared with the placebo
group [0.8(1.3) vs. 3.9(2.9), mean(SD) p = 0.0004] (Fig. 2).
Pain scores on passive movement six hours after the
surgery tended to be lesser in the dexamethasone group
[3.2(2.6) vs. 5.5(3.8), mean(SD) p = 0.055] (Fig. 3) although
this did not achieve statistical significance. Cumulative
morphine consumption 24 h after the surgery (mg) was
lesser in the dexamethasone group than in the placebo
group [7.7(8.3) vs. 15.1(9.4), mean(SD) respectively;
p = 0.04] (Fig. 4).
Cortisol concentration (ng/ml) measured in saliva was
significantly lesser in the dexamethasone group on the
first postoperative evening [0.7(0.8) vs. 3.8(3.4), mean(SD);
p = 0.01].
Pain scores measured at rest and on passive move-
ments at the other time points studied were similar in
the two groups (Figs. 2 and 3).
Compared with those in the placebo group, patients in
the dexamethasone group had lesser systolic blood pres-
sure (mmHg), 6 h postoperatively [112(38) vs. 132(40),
mean(SD) p = 0.02].
Fig. 1 Flow diagram, showing data about enrollment, allocation, follow-up and statistical analysis
Table 1 Patient Characteristics
Dexamethasone group Placebo group p value
Gender (Female/Male) 8/5 12/5
Age (years) mean (SD) 74 (20.3) 71.9 (19.5) 0.38
BMI (kg/m2) mean (SD) 21.4 (7.2) 23.4 (7.4) 0.18
Fractured side (Right/Left) 6/7 7/10
Data displayed as number of cases. BMI Body Mass Index
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Patients in the two groups were similar in terms of
incidence of opioid related side effects, nausea/vomiting,
sedation and pruritus. No adverse events thought to be as-
sociated with dexamethasone administration were detected.
Discussion
The most important finding of this study is that single
low dose of dexamethasone administered preoperatively
has a significant analgesic effect in the early postopera-
tive period after operative fixation of FNF.
Dexamethasone prophylaxis has been used in dental
surgery [13] and thyroidectomy [14, 15], and shown to
be a safe and effective method to reduce significantly the
postoperative analgesic requirement. Similar doses of
dexamethasone administered intravenously preopera-
tively decrease total analgesic requirements in patient
undergoing total laparoscopic hysterectomy [16, 17]. In
a recent meta-analysis by Lunn and Kehlet, 17 studies with
data from 1081 patients were included and highlighted
that high dose of dexamethasone have analgesic effect
after hip and knee replacement [18]. De Oliveira et al. in-
cluded 24 randomised clinical trials with 2751 patients in
a meta-analysis. There conclusion were similarly, dexa-
methasone at doses more than 0.1 mg/kg is an effective
adjunct in multimodal strategies to reduce postoperative
pain and opioid consumption after surgery [19]. Prior to
this study, the potential analgesic benefits of preoperative
dexamethasone to patients undergoing fixation of FNF
Fig. 2 Showing Numeric rating scale (NRS) pain scores at rest in the first postoperative week. Primary outcome is NRS pain score 6 h after the surgery
Fig. 3 Showing Numeric rating scale (NRS) pain scores on passive movement in the first postoperative week
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had not been studied. We believe that such benefits as we
have demonstrated have particular significance in this
population in view of their possible contribution to re-
habilitation, a critical determinant of overall outcome in
this setting. Although we did not follow patients in this
study to identify subsequent benefits of preoperative dexa-
methasone or persistent post-surgical pain (PPSP), we and
others have demonstrated that the quality of early post-
operative pain relief is a consistent and important de-
terminant of the incidence of PPSP [20].
In the dexamethasone group one patient’s preoperative
saliva cortisol level was greater than the normal range
and the postoperative pain scores were higher than the
mean at each time point. This might raise the possibility
of patients with high preoperative cortisol levels not
benefiting from preoperative low dose dexamethasone.
This can be only a theoretic explanation so further re-
search is needed in this field.
Our study has certain limitations. The result is positive
in terms of primary outcome; however data were studied
from only 13 patients in the dexamethasone group be-
cause four patients were excluded. This could have con-
tributed to relative under-powering and Type II error in
secondary outcomes. We reported no dexamethasone
related side effects. The study was not powered to detect
clinically meaningful difference, in terms of dexametha-
sone related side effects, with regard to safety. Our sample
size was small but the study was constructed to demon-
strate the analgesic effect of dexamethasone, which may
didn’t appeared from the pain scores but in the tendency
of lower cumulative morphine consumption.
Conclusions
Our findings indicate that single dose of dexametha-
sone 0.1 mg kg−1 administered immediately preopera-
tively confers significant analgesic benefit in the early
postoperative period after the operative fixation of
fractured neck of femur. We have also demonstrated that
the patients’ saliva cortisol level were lesser on the first
postoperative evening, suggesting an inhibitory effect of
the dexamethasone on the hypothalamic-pituitary-
adrenal axis.
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